Drug intelligence / Profile preview

aciclovir + hydrocortisone

Development stage
Unknown
Lead developer
Medivir
Modality
Small Molecules
Administration
Topical
01

Overview

Aciclovir Duo is a topical fixed-dose combination cream containing the antiviral agent aciclovir (5%) and the mild corticosteroid hydrocortisone (1%). Developed as a generic alternative to Zovirax Duo, it is manufactured by the Moldovan pharmaceutical company Farmaprim. The combination is indicated for the early treatment of recurrent herpes labialis (cold sores) in adults and adolescents aged 12 years and older to reduce the progression of cold sore episodes to ulcerative lesions and shorten healing times. Aciclovir acts by selectively inhibiting viral DNA polymerase and terminating viral DNA chain synthesis, while hydrocortisone reduces the localized inflammatory response by agonizing the glucocorticoid receptor, thereby preventing the progression of cold sores to ulcerative lesions.

Brand names
Aciclovir DuoXereseZovirax Duo
Other names
aciclovir/hydrocortisoneacyclovir + hydrocortisoneacyclovir/hydrocortisone
02

Targets

GR (Glucocorticoid receptor)Herpesvirus DNA polymeraseHSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))DNA polymerase family

Beyond the preview

Go deeper on aciclovir + hydrocortisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aciclovir + hydrocortisone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call